Molecular epidemiology of tuberculosis in Tasmania and genomic characterisation of its first known multi-drug resistant case

PloS One
Sanjay S GautamRonan F O'Toole

Abstract

The origin and spread of tuberculosis (TB) in Tasmania and the types of strains of Mycobacterium tuberculosis complex (MTBC) present in the population are largely unknown. The aim of this study was to perform the first genomic analysis of MTBC isolates from Tasmania to better understand the epidemiology of TB in the state. Whole-genome sequencing was performed on cultured isolates of MTBC collected from 2014-2016. Single-locus variant analysis was applied to determine the phylogeny of the isolates and the presence of drug-resistance mutations. The genomic data were then cross-referenced against public health surveillance records on each of the cases. We determined that 83.3% of TB cases in Tasmania from 2014-2016 occurred in non-Australian born individuals. Two possible TB clusters were identified based on single locus variant analysis, one from November-December 2014 (n = 2), with the second from May-August 2015 (n = 4). We report here the first known isolate of multi-drug resistant (MDR) M. tuberculosis in Tasmania from 2016 for which we established its drug resistance mutations and potential overseas origin. In addition, we characterised a case of M. bovis TB in a Tasmanian-born person who presented in 2014, approximately 40...Continue Reading

References

Jan 18, 2002·Antimicrobial Agents and Chemotherapy·Noman SiddiqiSeyed E Hasnain
Oct 8, 2003·Systematic Biology·Stéphane Guindon, Olivier Gascuel
Feb 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Sebastien GagneuxPeter M Small
Nov 1, 2006·Emerging Infectious Diseases·M Cristina GutierrezPhilip Supply
Feb 22, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Giovanni Battista MiglioriUNKNOWN SMIRA/TBNET Study Group
Dec 24, 2008·Antimicrobial Agents and Chemotherapy·Angela M StarksJames E Posey
Feb 14, 2009·Journal of Clinical Microbiology·Michael B ReedMarcel A Behr
Dec 8, 2009·BMC Infectious Diseases·Judit BarniolThomas Junghanss
Mar 20, 2012·BMC Infectious Diseases·Zaza Kamper-JørgensenTroels Lillebaek
Aug 7, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Chongguang YangQian Gao
Nov 20, 2012·The Lancet Infectious Diseases·Timothy M WalkerTim E A Peto
Apr 16, 2013·The Medical Journal of Australia·Tony Kirby
May 3, 2013·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·S YenR F O'Toole
Aug 21, 2013·The European Respiratory Journal·Roland DielAlbert Nienhaus
Oct 12, 2013·The European Respiratory Journal·Andreas SandgrenEnrico Girardi
Dec 20, 2013·Journal of Clinical Microbiology·Timothy C RodwellAntonino Catanzaro
Mar 29, 2014·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·Richard G White, Rein M G J Houben
Jun 4, 2014·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S O SimonsD van Soolingen
May 12, 2015·Nature Communications·Vegard EldholmFrancois Balloux
May 29, 2015·Genome Medicine·Francesc CollTaane G Clark
Jul 9, 2016·Genome Announcements·Micheál Mac AogáinRonan F O'Toole
Feb 23, 2017·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·G J FoxD Menzies
Sep 1, 2003·Health Information Management : Journal of the Health Information Management Association of Australia·Pam Taylor

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
Assay
Genotyping
Profiler
biopsy

Software Mentioned

PhyML
Geneious
PhyResSE
SAMtools
TB Profiler

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

© 2022 Meta ULC. All rights reserved